World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01099605
Date of registration: 06/04/2010
Primary sponsor: United States Naval Medical Center, Portsmouth
Public title: Continuous Infusion of Local Anesthetic for Optimal Post Operative Pain Control Following Hemorrhoidectomy
Scientific title: Continuous Infusion of Local Anesthetic for Optimal Post Operative Pain Control Following Hemorrhoidectomy: A Randomized Double-blind Controlled Trial
Date of first enrolment: April 2010
Target sample size: 42
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01099605
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Ellie Mentler, MD
Address: 
Telephone: 757-314-0134
Email: ellie.mentler@med.navy.mil
Affiliation: 
Name:   Ellie Mentler, MD
Address: 
Telephone: 757-953-2454
Email: ellie.mentler@med.navy.mil
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients scheduled for hemorrhoidectomies at NMCP

Exclusion Criteria:

- Any patient with co-existing active purulent infection (i.e. abscess).

- Any patient who has had previous surgical intervention for his/her hemorrhoidal
disease. Previous simple incision to treat a thrombosed hemorrhoid is not considered
a surgical intervention for the purposes of this study. The minimal scar produced by
a small incision would not alter post-operative pain following removal of a
hemorrhoidal column.

- Any patient allergic to local anesthetics or oral pain medications

- Any patient with a history of chronic pain

- Any patient allergic to or has had an adverse reaction (i.e. history of
gastrointestinal bleed) to a non-steroidal anti-inflammatory drugs (NSAIDs)

- Any patient pregnant patient



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Hemorrhoids
Intervention(s)
Device: continuous infusion pump of bupivacaine
Device: placement of a continuous infusion pump
Primary Outcome(s)
VAS pain scales [Time Frame: 1 week]
Secondary Outcome(s)
Secondary ID(s)
CIP# 10.0042
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history